| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 20.819 | 92.453 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 20.819 | 92.454 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 19.999 | 75.304 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 820 | 17.150 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 774 | 15.259 |
| Employees | - | - | - | - | - | - | - | - | 2 | 2 |
Check the financial reports for the company - Medlovet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 1.084 | 5.846 |
| Current Assets | - | - | - | - | - | - | - | - | 31.347 | 58.734 |
| Inventories | - | - | - | - | - | - | - | - | 12.391 | 38.483 |
| Receivables | - | - | - | - | - | - | - | - | 18.841 | 18.481 |
| Cash | - | - | - | - | - | - | - | - | 115 | 1.770 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 815 | 16.069 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 31.617 | 48.510 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Medlovet S.r.l.